feed,title,long_url,short_url
BioRxiv,TMPRSS2 and RNA-dependent RNA polymerase are effective targets of therapeutic intervention for treatment of COVID-19 caused by SARS-CoV-2 variants (B.1.1.7 and B.1.351),https://biorxiv.org/cgi/content/short/2021.04.06.438540v1?rss=1,https://j.mp/3dJBNtH
BioRxiv,Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality,https://biorxiv.org/cgi/content/short/2021.04.07.438849v1?rss=1,https://j.mp/2R9VTpi
BioRxiv,Identification of SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of the nsp14 RNA Cap Methyltransferase,https://biorxiv.org/cgi/content/short/2021.04.07.438810v1?rss=1,https://j.mp/3wGHT70
BioRxiv,Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp14/nsp10 Exoribonuclease,https://biorxiv.org/cgi/content/short/2021.04.07.438812v1?rss=1,https://j.mp/3mFLAVX
BioRxiv,Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp15 Endoribonuclease,https://biorxiv.org/cgi/content/short/2021.04.07.438811v1?rss=1,https://j.mp/3t1Dl8U
BioRxiv,Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp3 Papain-like Protease,https://biorxiv.org/cgi/content/short/2021.04.07.438804v1?rss=1,https://j.mp/3fP8nNz
BioRxiv,Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 Helicase,https://biorxiv.org/cgi/content/short/2021.04.07.438808v1?rss=1,https://j.mp/3wE4gtx
BioRxiv,Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp12/7/8 RNA-dependent RNA Polymerase,https://biorxiv.org/cgi/content/short/2021.04.07.438807v1?rss=1,https://j.mp/39Qq3og
BioRxiv,Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of nsp5 Main Protease,https://biorxiv.org/cgi/content/short/2021.04.07.438806v1?rss=1,https://j.mp/3mBDVHZ
